Endovascular Treatment of Ruptured Brain AVMs in the Acute Phase of Hemorrhage

References

1. 1.↵
   1. Graf CJ,
   2. Perret GE,
   3. Torner JC

   . Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983; 58: 331–37

   PubMedWeb of Science
2. 2.↵
   1. Crawford PM,
   2. West CR,
   3. Chadwick DW,
   4. et al

   . Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986; 49: 1–10

   Abstract/FREE Full Text
3. 3.↵
   1. Brown RD Jr.,
   2. Wiebers DO,
   3. Forbes G,
   4. et al

   . The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988; 68: 352–57

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Ondra SL,
   2. Troupp H,
   3. George ED,
   4. et al

   . The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990; 73: 387–91

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Stapf C,
   2. Mohr JP,
   3. Choi JH,
   4. et al

   . Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 2006; 19: 63–68

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Stapf C

   . The rationale behind “A Randomized Trial of Unruptured Brain AVMs” (ARUBA). Acta Neurochir Suppl 2010; 107: 83–85

   CrossRefPubMed
7. 7.↵
   1. da Costa L,
   2. Wallace MC,
   3. Ter Brugge KG,
   4. et al

   . The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke 2009; 40: 100–05

   Abstract/FREE Full Text
8. 8.↵
   1. Hernesniemi JA,
   2. Dashti R,
   3. Juvela S,
   4. et al

   . Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 2008; 63: 823–29

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Meisel HJ,
   2. Mansmann U,
   3. Alvarez H,
   4. et al

   . Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 2002; 144: 879–87

   CrossRefPubMed
10. 10.↵
    1. Mast H,
    2. Young WL,
    3. Koennecke HC,
    4. et al

    . Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 1997; 350: 1065–68

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Alexander MJ,
    2. Tolbert ME

    . Targeting cerebral arteriovenous malformations for minimally invasive therapy. Neurosurgery 2006; 59: 178–83
12. 12.↵
    1. Hademenos GJ,
    2. Massoud TF

    . Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment. A theoretical analysis. Stroke 1996; 27: 1072–83

    Abstract/FREE Full Text
13. 13.↵
    1. Mansmann U,
    2. Meisel J,
    3. Brock M,
    4. et al

    . Factors associated with intracranial hemorrhage in cases of cerebral arteriovenous malformation. Neurosurgery 2000; 46: 272–79

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Stefani MA,
    2. Porter PJ,
    3. terBrugge KG,
    4. et al

    . Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke 2002; 33: 920–24

    Abstract/FREE Full Text
15. 15.↵
    1. Krings T,
    2. Hans FJ,
    3. Geibprasert S,
    4. et al

    . Partial “targeted” embolisation of brain arteriovenous malformations. Eur Radiol 2010; 20: 2723–31

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Katsaridis V,
    2. Papagiannaki C,
    3. Aimar E

    . Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008; 50: 589–97

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Saatci I,
    2. Geyik S,
    3. Yavuz K,
    4. et al

    . Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg 2011; 115: 78–88

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Andreou A,
    2. Ioannidis I,
    3. Lalloo S,
    4. et al

    . Endovascular treatment of intracranial microarteriovenous malformations. J Neurosurg 2008; 109: 1091–97

    CrossRefPubMed
19. 19.↵
    1. van Rooij WJ,
    2. Sluzewski M,
    3. Beute GN

    . Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007; 28: 172–77

    Abstract/FREE Full Text
20. 20.↵
    1. Delgado Almandoz JE,
    2. Romero JM

    . Advanced CT imaging in the evaluation of hemorrhagic stroke. Neuroimaging Clin N Am 2011; 21: 197–213

    CrossRefPubMed
21. 21.↵
    1. van Rooij WJ,
    2. Sluzewski M

    . Endovascular occlusion of high-flow intracranial arteriovenous shunts: technical note. Neuroradiology 2007; 49: 1029–31

    CrossRefPubMedWeb of Science
22. 22.↵
    1. van Rooij WJ,
    2. Sluzewski M

    . Curative embolization with Onyx of dural arteriovenous fistulas with cortical venous drainage. AJNR Am J Neuroradiol 2010; 31: 1516–20

    Abstract/FREE Full Text
23. 23.↵
    1. Cognard C,
    2. Januel AC,
    3. Silva NA Jr.,
    4. et al

    . Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx. AJNR Am J Neuroradiol 2008; 29: 235–41

    Abstract/FREE Full Text
24. 24.↵
    1. Smith SD,
    2. Eskey CJ

    . Hemorrhagic stroke. Radiol Clin North Am 2011; 49: 27–45

    CrossRefPubMed
25. 25.↵
    1. Steiner T,
    2. Kaste M,
    3. Forsting M,
    4. et al

    . Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22: 294–316

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Masdeu JC,
    2. Irimia P,
    3. Asenbaum S,
    4. et al

    . EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force. Eur J Neurol 2006; 13: 1271–83

    CrossRefPubMed